Vincenti ITN023ST: Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
收藏官方服务：
资源简介：
This study evaluates whether belatacept and a combination of anti-rejection drugs prevents non-human leukocyte antigen identical renal transplant rejection allowing safe anti-rejection therapy withdrawal one year post-transplant
提供机构：
ImmPort创建时间：
2015-12-14
